Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226249893> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- W4226249893 abstract "You have accessJournal of UrologyCME1 May 2022MP18-16 VOIDING TIME AS A PROXY FOR URINARY OBSTRUCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS Gaurav Pahouja, Parth Patel, Enrique Blanco Martinez, and Kevin T. McVary Gaurav PahoujaGaurav Pahouja More articles by this author , Parth PatelParth Patel More articles by this author , Enrique Blanco MartinezEnrique Blanco Martinez More articles by this author , and Kevin T. McVaryKevin T. McVary More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002551.16AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: We sought to investigate voiding time (VT) in asymptomatic and symptomatic men, and compare VT to other uroflowmetric parameters such as maximum flow rates (Qmax) as a possible solution to disparity related lack of access to more standard urodynamic testing in LUTS patients. METHODS: We conducted a controlled prospective study on a total of 30 patients. Adults age ≥18 were included. Exclusion criteria were those with ongoing medical therapy for LUTS or a history of invasive therapy for LUTS. Patients completed the International Prostate Symptom Score (IPSS) questionnaire, uroflowmetry, and post-void residual (PVR) testing. Symptomatic LUTS was defined as an IPSS ≥8. RESULTS: On univariate analysis, men with a symptomatic LUTS had a significantly longer VT than asymptomatic men (30.60 seconds (Interquartile rage [IQR] 24.2-42.4) vs 20.50 seconds (IQR 16.6-40.5), p=0.043). When controlling for all other factors, VT was not otherwise associated with age, race, or BMI. There was no significant difference in Qmax between symptomatic and asymptomatic patients (13.40 seconds (IQR 8.7-19.9) vs 20.5 seconds (IQR 11.7-31.8), p-0.07). No differences were found based on PVR (p=0.51). Our study also demonstrated that the sensitivity of a VT ≥23.5 seconds, or probability of observing a VT exceeding 23.5 seconds when the patient has a symptomatic IPSS, is 85%. On sensitivity and specificity analysis, there was no difference between the abilities of Qmax and VT to predict that a patient would have symptomatic LUTS (p=0.80). CONCLUSIONS: We found that VT was as accurate as Qmax in predicting symptomatic IPSS scores. This novel finding can improve the ability to diagnose and treat LUTS, especially in primary care offices and underserved areas. Source of Funding: None © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e302 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Gaurav Pahouja More articles by this author Parth Patel More articles by this author Enrique Blanco Martinez More articles by this author Kevin T. McVary More articles by this author Expand All Advertisement PDF DownloadLoading ..." @default.
- W4226249893 created "2022-05-05" @default.
- W4226249893 creator A5033036781 @default.
- W4226249893 creator A5047934585 @default.
- W4226249893 creator A5063332770 @default.
- W4226249893 creator A5083363461 @default.
- W4226249893 date "2022-05-01" @default.
- W4226249893 modified "2023-09-27" @default.
- W4226249893 title "MP18-16 VOIDING TIME AS A PROXY FOR URINARY OBSTRUCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS" @default.
- W4226249893 doi "https://doi.org/10.1097/ju.0000000000002551.16" @default.
- W4226249893 hasPublicationYear "2022" @default.
- W4226249893 type Work @default.
- W4226249893 citedByCount "0" @default.
- W4226249893 crossrefType "journal-article" @default.
- W4226249893 hasAuthorship W4226249893A5033036781 @default.
- W4226249893 hasAuthorship W4226249893A5047934585 @default.
- W4226249893 hasAuthorship W4226249893A5063332770 @default.
- W4226249893 hasAuthorship W4226249893A5083363461 @default.
- W4226249893 hasConcept C119060515 @default.
- W4226249893 hasConcept C121608353 @default.
- W4226249893 hasConcept C126322002 @default.
- W4226249893 hasConcept C126894567 @default.
- W4226249893 hasConcept C2776235491 @default.
- W4226249893 hasConcept C2776547966 @default.
- W4226249893 hasConcept C2777910003 @default.
- W4226249893 hasConcept C2779478474 @default.
- W4226249893 hasConcept C29456083 @default.
- W4226249893 hasConcept C71924100 @default.
- W4226249893 hasConceptScore W4226249893C119060515 @default.
- W4226249893 hasConceptScore W4226249893C121608353 @default.
- W4226249893 hasConceptScore W4226249893C126322002 @default.
- W4226249893 hasConceptScore W4226249893C126894567 @default.
- W4226249893 hasConceptScore W4226249893C2776235491 @default.
- W4226249893 hasConceptScore W4226249893C2776547966 @default.
- W4226249893 hasConceptScore W4226249893C2777910003 @default.
- W4226249893 hasConceptScore W4226249893C2779478474 @default.
- W4226249893 hasConceptScore W4226249893C29456083 @default.
- W4226249893 hasConceptScore W4226249893C71924100 @default.
- W4226249893 hasIssue "Supplement 5" @default.
- W4226249893 hasLocation W42262498931 @default.
- W4226249893 hasOpenAccess W4226249893 @default.
- W4226249893 hasPrimaryLocation W42262498931 @default.
- W4226249893 hasRelatedWork W2023520015 @default.
- W4226249893 hasRelatedWork W2041289234 @default.
- W4226249893 hasRelatedWork W2092700236 @default.
- W4226249893 hasRelatedWork W2097436220 @default.
- W4226249893 hasRelatedWork W2100669542 @default.
- W4226249893 hasRelatedWork W2141781475 @default.
- W4226249893 hasRelatedWork W2811320370 @default.
- W4226249893 hasRelatedWork W2979153818 @default.
- W4226249893 hasRelatedWork W2981467331 @default.
- W4226249893 hasRelatedWork W3159061506 @default.
- W4226249893 hasVolume "207" @default.
- W4226249893 isParatext "false" @default.
- W4226249893 isRetracted "false" @default.
- W4226249893 workType "article" @default.